Hepatitis A: disease burden and current childhood vaccination strategies in the United States.
Hepatitis A can be a serious disease and represents a substantial health and economic burden. In recent years, a decline in the number of cases of hepatitis A has been observed, which has been attributed in part to the implementation of vaccination policies in states with high disease incidence. In May 2006, the Advisory Committee on Immunization Practices published updated recommendations to include routine hepatitis A vaccination for all children beginning at 12 to 23 months of age. In this review, information on hepatitis A disease burden is presented with a discussion on the new recommendations and implementation of hepatitis A vaccination.
Koslap-Petraco
Mary Beth
MB
Suffolk County Department of Health Services, Hauppauge, NY 11788, USA. MaryBeth.Petraco@suffolkcountyny.gov
Shub
Mitchell
M
Judelsohn
Richard
R
D000368:Aged; D002648:Child; D002675:Child, Preschool; D017281:Cost of Illness; D017277:Drug Approval; D006287:Health Planning Guidelines; D006291:Health Policy; D006506:Hepatitis A / Q000150:complications / Q000453:epidemiology* / Q000517:prevention & control* / Q000635:transmission; D022362:Hepatitis A Vaccines / Q000600:supply & distribution; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration; D007115:Immunization Schedule; D015994:Incidence; D007223:Infant; D032541:Mass Vaccination / Q000458:organization & administration; D009017:Morbidity; D011159:Population Surveillance; D011634:Public Health; D012307:Risk Factors; D012720:Severity of Illness Index; D012959:Socioeconomic Factors; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration; D014611:Vaccination / Q000379:methods / Q000706:statistics & numerical data
D022362:Hepatitis A Vaccines